Welcome, 2025!? Let’s make this the year of true breakthroughs?in cancer therapy. Cancer is a smart and resilient beast, but we believe that one day, we will manage it as any chronic condition. At FREZENT Biological Solutions, our mission is to give cancer patients confidence in their future. We are developing a treatment that can prevent residual cancer cells from re-emerging, ultimately reducing the number of deaths caused by recurrent cancer. This year more than ever, we are committed to pushing the boundaries of what’s currently possible and joining forces with the brightest human minds and?the power of?AI to bring our vision closer to reality for over 30 million people living with cancer. Join us on this journey. Together, we will conquer the beast. Take a moment, look us up, visit our website and learn about our novel work. We are keen to learn about your work and how together we can beat cancer. #CureCancer #OncologyInnovation #NextGenTherapeutics
FREZENT Biological Solutions
生物技术
New York,NY 260 位关注者
Changing the prognosis for patients with advanced stage cancer.
关于我们
- 网站
-
https://www.frezent.com
FREZENT Biological Solutions的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- New York,NY
- 类型
- 私人持股
- 创立
- 2017
地点
-
主要
7 Pennsylvania Plaza
US,NY,New York,10001
FREZENT Biological Solutions员工
-
Michael Baer
Chief Marketing Officer | Growth Expert | Omnichannel Marketing | Transformation | B2B | Brand Strategy | Healthcare | Marketing Services |…
-
Efrat Eliyahu
Assistant Professor at Mount Sinai School of Medicine
-
Saliha Nafil
Lead Scientist at FREZENT Biological Solutions Inc.
-
Lina Freage-Kahn
Co-Founder and Chief Scientific Officer at Frezent Biological Solutions Inc.